Results 211 to 219 of about 623,178 (219)

A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval

Journal of Clinical Epidemiology, 2006
Sarah M Greene
exaly  

Coordination and management of multicenter clinical studies in trauma: Experience from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study

Resuscitation, 2012
Mohammad H Rahbar
exaly  

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Ca-A Cancer Journal for Clinicians
Yan Yu, Diansheng Zhong, Lin Wu
exaly  

Cataract Surgery Outcomes in UveitisThe Multicenter Uveitis Steroid Treatment Trial

Ophthalmology, 2016
Janet T. Holbrook, John H Kempen, Hatice Nida Şen   +2 more
exaly  

Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Yin Zhao, Wen-Fei Li, Na Liu
exaly  

Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials

Statistics in Biopharmaceutical Research, 2017
David Venet, Catherine Legrand, Lieven Desmet   +2 more
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Ning Li, Min Hao
exaly  

Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical Trial

Academic Emergency Medicine, 2001

exaly  

Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013: A Multicenter Observational Study

Journal of Allergy and Clinical Immunology: in Practice, 2015
Kohei Hasegawa, Mehdi Khosravi
exaly